Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ullem Scott B., Chief Financial Officer. Officer active across 3 companies, notably Edwards Lifesciences Corp. In total, 63 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €890k. Activity tracked since 4 May 2021. The latest transaction was disclosed on 11 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ullem Scott B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
183 shares@ US$122.779310.9% of flowCommon StockSEC:0001127602-24-024722:0
25 of 63 declarations
About Ullem Scott B.
Ullem Scott B. is Directeur Financier. He has 63 filings in total, and in the sampled recent filings the transactions run from 2021-05-06 to 2026-05-11, with 0 EUR of buys and 890019 EUR of sells, the most frequent transaction nature being Levée d'options. He is also linked to Edwards Lifesciences Corp, Illumina, INC. and Berry Global Group, INC.